Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
Study Information
Alliance Study ID: CALGB-79809
NCT Study ID (ClinicalTrials.gov): NCT00022087
Alliance Committee: Cancer Control
Disease or Cancer Type: Breast Cancer
Alliance Study Chair: Charles L. Shapiro, MD
Status: COMPLETED
Study Description
RATIONALE: Zoledronate plus calcium and vitamin D may prevent bone loss in patients receiving adjuvant chemotherapy for breast cancer. It is not yet known which regimen is more effective in preventing bone loss.
PURPOSE: This randomized phase III trial is comparing two regimens of zoledronate plus calcium and vitamin D to see how well they work in preventing bone loss in women who are receiving adjuvant chemotherapy for breast cancer.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information